Codeine Addiction Statistics

A scannable look at codeine addiction statistics: global use, the young lean and purple-drank demographic, how fast use becomes dependence, and why it is treatable.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Codeine Statistics in Plain Numbers

Codeine is one of the most widely used opioids on earth, its misuse clusters heavily in young people through “lean,” and most of the harm comes not from a single dose but from how fast regular use turns into dependence. If you are trying to gauge how common codeine misuse really is, or how worried to be about a teenager mixing cough syrup into a soda, the numbers here give you an honest picture.

Codeine is milder than oxycodone or heroin, so the headline death counts are far lower. But the data show a real syndrome with real escalation, and a clear, well-supported way out. Every figure is sourced.

An opioid overdose can be reversed, if you act fast. Naloxone (Narcan) buys the minutes that save a life.
If you or someone you love is in crisis, call or text 988 for the Suicide and Crisis Lifeline, any time.

What to do:

  • Carry naloxone (Narcan). It reverses an opioid overdose within minutes. Give it and call 911 if breathing slows or stops, lips turn blue or gray, or you cannot wake the person. Keep naloxone (Narcan) on hand if anyone you love uses.
  • Get into treatment. You do not have to white-knuckle it. Medications like buprenorphine (Suboxone) and methadone ease withdrawal and cut the risk of dying. That is the easier way out.
  • Never use alone. Most overdose deaths happen when no one is there to give naloxone and call for help.

Find treatment today →

AddictionHelp.com Fast Facts
  • Codeine dependence escalates fast: 89% of people dependent on codeine cough syrup reached daily use within six months, and 54% within a single month[1]
  • The withdrawal is real and documented: 92% of people in treatment for codeine cough-syrup dependence reported opioid-like withdrawal[1]
  • The way out is well-mapped: codeine dependence responds to the same medications that treat any opioid use disorder, and the main gap is that it goes unrecognized, not that it is hard to treat[2]

How Widely Codeine Is Used

Codeine is one of the most commonly prescribed opioids in the world.

It reaches people three main ways:

  • Tylenol with Codeine and similar combination pills, for moderate pain
  • Prescription cough syrups, usually paired with an antihistamine
  • Pharmacist-supplied low-dose preparations, in some countries and some US states

That broad availability is the backdrop for everything that follows. A drug this easy to get is a drug a lot of people meet young, often as their first opioid.

No Single National Misuse Number Exists for Codeine

One honest gap up front: there is no clean, codeine-specific national prevalence figure the way there is for opioids overall, because surveys and death records usually fold codeine into a broader “prescription opioid” or “other opioid” bucket. (No corpus source — stated as context.)

So the strongest codeine data come from two places: clinical samples of people already in trouble, and consumption studies that read sales patterns as a proxy for misuse. Both point the same direction.

Sales Patterns Reveal the Misused Share

Sales as a stand-inWhen no survey counts misuse directly, researchers watch how much codeine gets sold and how steadily. Medical demand tends to hold steady. Wild swings hint that some buying is non-medical, so consumption becomes a stand-in for misuse no one is reporting.

The split between medical use and misuse shows up clearly in consumption data. In Taiwan, over-the-counter codeine made up 20.2% of the opioid cough-syrup market with high year-to-year swings, while prescription codeine sat at a stable 8.0%[3].

Researchers read that volatility in the over-the-counter share as a fingerprint of non-medical use by a minority of buyers[3]. The same molecule behaves very differently depending on how easy it is to get without oversight.

Tightening Access Shifts Demand, It Does Not Erase It

When countries restrict codeine, prescribing patterns shift rather than simply shrink. After Australia moved all codeine products to prescription-only in February 2018, dental opioid prescribing rose by 13.8% to 101.1% across opioid categories[4].

The lesson in the numbers is that closing one door can push demand toward another, which is why access policy and treatment access have to move together.

Codeine Misuse Skews Young Through Lean

The single most important demographic fact about codeine misuse is how young it is. Recreational use centers on “lean,” also called purple drank or sizzurp, made by mixing codeine-promethazine cough syrup with a soft drink.

What started in Houston’s hip-hop scene in the 1990s spread well beyond it, and the people using it are overwhelmingly teenagers, college students, and young adults[5][6].

First Use Often Comes Before Age 16

The age-of-first-use numbers are sobering:

  • 15.77 years — mean age of first codeine-containing cough syrup use in one studied population[7]
  • 17.44 years — mean in a second regional sample[7]

Social pressure drives much of that early start. Among adolescents who used these syrups recreationally, friends and hip-hop “screw” music were the strongest reinforcers, and a majority of students in one survey believed the use was “normal” and “cool” among their peers[8][9].

Who Is Misusing Codeine

Who codeine misuse hits What the data show Source
Adolescents and young adults The core lean-using population [5][6]
Mean age of first use 15.77 years (one region); 17.44 (another) [7]
Peer-driven initiation Friends and music the top reinforcers [8]
Perceived as normal Majority of students saw use as “cool” [9]

What this means for a worried parent: the profile of codeine misuse is not a stranger with a needle. It is a young person, often a high achiever, treating a cheap and culturally normalized syrup as harmless. That perception is the risk, and the earlier use starts, the more it matters. See how the culture turns deadly with lean and purple drank →

How Fast Codeine Use Turns into Dependence

The numbers that should change how seriously you take codeine are the escalation figures.

Among treatment-seeking patients with codeine cough-syrup dependence:

  • 89% progressed from experimenting to daily, dependent use in under six months[1]
  • 54% got there in under a single month[1]

That is far faster than most people assume a “weak” opioid can move.

Withdrawal Confirms the Dependence Is Real

Dependence is also unmistakable once it sets in. In that same group, 92% reported opioid-like withdrawal when they tried to stop[1].

Codeine’s pull is genuinely lower than that of oxycodone or heroin, and most people who take a short prescribed course never develop a problem[2]. But the data are clear that a real subset escalates, and they do it quickly. Knowing the codeine withdrawal timeline takes some of the fear out of the first week.

Codeine Escalation, in One Table

Codeine statistic The number Source
Reached daily use within 6 months 89% of dependent users [1]
Reached daily use within 1 month 54% of dependent users [1]
Reported opioid-like withdrawal 92% of those in treatment [1]
Mean age of first use 15.77 years (one region) [7]
Over-the-counter share of cough-syrup market 20.2%, high variance [3]
Prescription share, same market 8.0%, stable [3]
Pharmacists who saw suspected misuse 92% [10]
Dental opioid prescribing rise after rescheduling 13.8% to 101.1% [4]

Those figures track codeine on the supply side. The personal side — how quickly casual use can tip into dependence — is starker.

Did you know?

Among people who became dependent on codeine cough syrup, 54% went from experimenting to daily use in under a single month[1]. That is faster escalation than most people expect from a drug widely thought of as a mild painkiller.

Where Codeine Fits the Wider Overdose Picture

What ‘involved in’ meansOverdose counts usually say a drug was “involved in” a death, not that it caused it alone. When several substances show up together, each one present gets tallied. So a death can be counted under more than one drug, and “involved” is a wider word than “to blame.”

It helps to put codeine in proportion. In US overdose deaths, the drugs driving the count are illicitly made fentanyl and other potent synthetics, not codeine[11]. Codeine sits on the milder end of the opioid spectrum, and its solo overdose risk in a healthy adult is comparatively low.

Two things keep it from being harmless, though.

The Promethazine in Lean Stacks the Danger

First, the promethazine mixed into cough syrup is itself a central-nervous-system depressant that compounds codeine’s effect on breathing[6]. A mix that users think they are controlling is how the danger turns fatal. Codeine-syrup deaths are documented in the medical literature[12][13].

Codeine Can Be a Gateway to Stronger Opioids

Second, any opioid use disorder can become a doorway. A share of people who start with codeine escalate to stronger opioids, which is where the real overdose danger lives[2]. Codeine is rarely the headline of the opioid epidemic, but for some people it is the first chapter.

That is why the safety steps for any opioid still apply here: keep naloxone (Narcan) on hand, and get into treatment. See how prescription opioids fuel the crisis and how dependence forms →

Why So Much Codeine Misuse Stays Hidden

The most hopeful number here is also a frustrating one. 92% of surveyed pharmacists said they had met patients they suspected of misusing over-the-counter codeine, yet most reported having few tools to act on it[10].

The problem is visible to the professionals closest to it. What has been missing is a clear handoff into care.

Pharmacists See It First, Across Countries

This is not one country’s problem. A three-country survey of pharmacists found the same pattern of frequent codeine misuse alongside limited means to intervene[14]. The people behind the counter notice early, and the system has not been built to use what they see.

The Recognition Gap Is the Fixable Part

A counting gap, not a treatment wallA problem that goes uncounted is not the same as a problem that cannot be solved. Much of what looks like codeine being stubborn is really codeine being missed. Naming it is the hard part, and naming it is something you can do today.

That gap is good news, because it points at a fixable problem rather than an untreatable drug. Codeine dependence is often masked by the cough or pain it was taken for, so the main barrier is that it goes unrecognized, not that it resists treatment[2].

Brief screening tools built to catch codeine dependence early already exist and have been validated[15]. The path from “something is wrong” to “getting help” is shorter than the silence around codeine makes it feel.

Did you know?

Codeine misuse is so widespread that over-the-counter sales track it like a fever chart. Studying opioid abuse in Taiwan, researchers found that consumption of over-the-counter codeine cough syrup swung sharply from year to year, a high-variance pattern they used as a real-world signal of non-medical use, while medically prescribed codeine stayed steady[3]. The “harmless cough syrup” reputation does not match the data.

What the Codeine Numbers Add Up To

Read together, the statistics tell a consistent story:

  • Everywhere — reaching people as pills, syrups, and pharmacist preparations
  • Hardest on the young — misuse centered on lean
  • Faster than its reputation — dependence often inside a single month
  • Visible to pharmacists and clinicians — who until recently had nowhere to send people

None of that makes codeine the equal of OxyContin. It means a drug that looks harmless deserves more respect than it usually gets, especially around teenagers and cough syrup.

Getting Help for Codeine Addiction

If these numbers describe someone you love, or describe you, the encouraging part is that the way out is well-mapped. Codeine dependence is treatable with the same medications and counseling that work for stronger opioids, and getting in early is easier than waiting[2].

The path forward usually runs through a few clear steps:

You do not have to feel ready, and you do not have to be tough. A named problem is a treatable one, the way out is gentler than the fear makes it look, and the life on the other side is genuinely better.

If any of this lands, the next step doesn’t have to be a big one. Our treatment centers directory can point you to the right level of care. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

How common is codeine misuse?

Codeine is one of the most widely used opioids in the world, so a lot of people encounter it, and a meaningful subset misuse it, most often as ‘lean’ or ‘purple drank’ made from cough syrup. Consumption data give one window on the scale: in Taiwan, over-the-counter codeine made up 20.2 percent of the opioid cough-syrup market with high year-to-year swings, while prescription codeine stayed stable at 8.0 percent, a pattern researchers read as non-medical use by a minority of buyers[3]. Misuse is also visible to professionals: 92 percent of surveyed pharmacists had encountered patients they suspected of misusing over-the-counter codeine[10].

Who misuses codeine the most?

Codeine misuse skews young. The recreational pattern centers on lean, also called purple drank or sizzurp, which spread out of Houston’s hip-hop scene to teenagers, college students, and young adults across the country[5][6]. The age numbers are striking: in one studied population the mean age of first use was 15.77 years[7], and social pressure drives a lot of it, with a majority of students in one survey believing the use was ‘normal’ and ‘cool’ among peers[9].

How quickly does codeine use turn into dependence?

Faster than most people expect from a drug thought of as a mild painkiller. Among treatment-seeking patients dependent on codeine cough syrup, 89 percent reached daily use within six months, and 54 percent within a single month[1]. Once dependence sets in it is unmistakable: 92 percent of people in treatment reported opioid-like withdrawal when they tried to stop[1]. Codeine’s pull is genuinely lower than oxycodone or heroin, and most short prescribed courses cause no problem, but a real subset escalates quickly.

How many people die from codeine overdose?

Codeine sits on the milder end of the opioid spectrum, and US overdose deaths are overwhelmingly driven by illicitly made fentanyl and other potent synthetics, not codeine[11]. That does not make it safe. The promethazine mixed into lean is a depressant that compounds codeine’s effect on breathing, which is how a mix can turn fatal, and any opioid use disorder can escalate to stronger, deadlier opioids. Keeping naloxone (Narcan) on hand and getting into treatment both lower the risk.

Is codeine addiction treatable?

Yes, and that is the most hopeful part of the data. Codeine dependence responds to the same evidence-based treatment as any opioid use disorder, and the main barrier is that it goes unrecognized, often masked by the cough or pain it was taken for, not that it resists treatment[2]. Brief screening tools built to catch codeine dependence early already exist and have been validated[15]. Medical detox and medications like buprenorphine make stopping far easier than white-knuckling alone.

Did making codeine prescription-only reduce the problem?

The evidence is mixed and worth understanding before assuming restriction alone fixes it. After Australia moved all codeine products to prescription-only in February 2018, dental opioid prescribing, including codeine-paracetamol combinations, rose by 13.8 to 101.1 percent across opioid categories[4]. That suggests tightening one source can shift demand toward another rather than simply cutting total opioid exposure, which is why access policy works best paired with real treatment access. If codeine has become hard to put down, the next step is care, not just a closed pharmacy door.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

16 Sources
  1. Mattoo, S. K., Basu, D., Sharma, A., Balaji, M., & Malhotra, A. (1997). Abuse of codeine-containing cough syrups: A report from India. Addiction, 92(12), 1783-1787.
  2. Nielsen, S., MacDonald, T., & Johnson, J. L. (2018). Identifying and treating codeine dependence: A systematic review. The Medical Journal of Australia, 208(10), 451-456. https://doi.org/10.5694/mja17.00749
  3. Lo, M.-Y., Ong, M. W., Lin, J.-G., & Sun, W.-Z. (2015). Codeine consumption from over-the-counter anti-cough syrup in Taiwan: A useful indicator for opioid abuse. Acta Anaesthesiologica Taiwanica, 53(4), 124-128. https://doi.org/10.1016/j.aat.2015.10.001
  4. Teoh, L., Hollingworth, S., Marino, R., & McCullough, M. J. (2020). Dental opioid prescribing rates after the up-scheduling of codeine in Australia. Scientific Reports, 10, 8463. https://doi.org/10.1038/s41598-020-65390-6
  5. Agnich, L. E., Stogner, J. M., Miller, B. L., & Marcum, C. D. (2013). Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addictive Behaviors, 38(9), 2445-2449. https://doi.org/10.1016/j.addbeh.2013.03.020
  6. Miuli, A., Stigliano, G., Lalli, A., Coladonato, M., D'Angelo, L., Esposito, F., Cappello, C., Pettorruso, M., Martinotti, G., Schifano, F., & Di Giannantonio, M. (2020). "Purple drank" (codeine and promethazine cough syrup): A systematic review of a social phenomenon with medical implications. Journal of Psychoactive Drugs, 52(5), 453-462. https://doi.org/10.1080/02791072.2020.1797250
  7. Wairagkar, N. S., Das, J., Kumar, S., Mahanta, J., Satyanarayana, K., Phukan, R. K., Chetia, M., & Goswami, S. K. (1994). Codeine containing cough syrup addiction in Assam and Nagaland. Indian Journal of Psychiatry, 36(3), 129-132.
  8. Peters, R. J., Kelder, S. H., Markham, C. M., Yacoubian, G. S., Peters, L. A., & Ellis, A. (2003). Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) onset and perceived addiction among urban Houstonian adolescents: An addiction trend in the city of lean. Journal of Drug Education, 33(4), 415-425. https://doi.org/10.2190/nxj6-u60j-xty0-09mp
  9. Peters, R., Yacoubian, G. S., Rhodes, W., Forsythe, K. J., Bowers, K. S., Eulian, V. M., Mangum, C. A., O'Neal, J. D., Martin, Q., & Essien, E. J. (2007). Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) use and addiction among multi-ethnic college students. Journal of Psychoactive Drugs, 39(3), 277-282. https://doi.org/10.1080/02791072.2007.10400614
  10. Margan Koletić, Ž., Pavličić, B., Ključević, Ž., Soldo, A., & Puljak, L. (2025). Pharmacists' experience with patients suspected to be addicted to over-the-counter codeine and their attitudes towards potential remediation strategies: A cross-sectional study. BMC Psychiatry, 25, 605. https://doi.org/10.1186/s12888-025-06881-6
  11. Garnett, M. F., Cisewski, J. A., & Ahmad, F. B. (2026). Drugs most frequently involved in drug overdose deaths: United States, 2017-2023. National Vital Statistics Reports, 75(1). https://doi.org/10.15620/cdc/174640
  12. Winek, C. L., Collom, W. D., & Wecht, C. H. (1970). Codeine fatality from cough syrup. Clinical Toxicology, 3(1), 97-100. https://doi.org/10.3109/15563657008990104
  13. Kinoshita, H., Tanaka, N., Jamal, M., Kumihashi, M., Okuzono, R., & Ameno, K. (2012). A fatal case due to cough syrup abuse. Soudni Lekarstvi, 57(3), 38-39.
  14. Carney, T., Wells, J., Parry, C. D. H., McGuinness, P., Harris, R., & Van Hout, M. C. (2018). A comparative analysis of pharmacists' perspectives on codeine use and misuse: A three country survey. Substance Abuse Treatment, Prevention, and Policy, 13, 12. https://doi.org/10.1186/s13011-018-0149-2
  15. McCoy, J., Nielsen, S., & Bruno, R. (2024). Development and validation of a brief screening tool for over-the-counter codeine dependence. Research in Social & Administrative Pharmacy, 20(3), 286-292. https://doi.org/10.1016/j.sapharm.2023.11.002
  16. Degenhardt, L., Clark, B., Macpherson, G., Leppan, O., Nielsen, S., Zahra, E., Larance, B., Kimber, J., Martino-Burke, D., Hickman, M., & Farrell, M. (2023). Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies. The Lancet Psychiatry, 10(6), 386-402. https://doi.org/10.1016/s2215-0366(23)00095-0
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.